CytoDyn Inc. Appoints Anthony D. Caracciolo as Chairman of the Board of Directors

CytoDyn Inc. , a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, today announced that Anthony D. Caracciolo has been appointed Chairman of the Board of Directors effective June 17, 2013.

http://it.tmcnet.com/news/2013/06/17/7211232.htm

CytoDyn Inc. Appoints Anthony D. Caracciolo as Chairman of the Board of Directors

Past Chairman, Gregory A. Gould, will remain a member of the Board of Directors and continue to serve as Chair of the Audit Committee.

http://eon.businesswire.com/news/eon/20130617006605/en/CytoDyn-Appoints-Anthony-D.-Caracciolo-Chairman-Board